Predictive modeling of clinical trial terminations using feature engineering and embedding learning
Magdalyn E Elkin1, Xingquan Zhu2
1Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA.
Scientific Reports
|February 11, 2021
Summary
Machine learning identifies factors linked to clinical trial termination and predicts outcomes. This approach aids stakeholders in planning and minimizing costs by understanding trial success probabilities.
Area of Science:
- Clinical trial management
- Data science in healthcare
- Predictive analytics
Background:
- Clinical trials are essential for medical advancement but face high termination rates.
- Understanding factors contributing to trial termination is crucial for optimizing research and resource allocation.
- Predictive models can help mitigate risks and improve the efficiency of clinical research.
Purpose of the Study:
- To identify common factors and markers associated with terminated clinical trials.
- To develop an accurate machine learning model for predicting clinical trial termination.
- To provide stakeholders with insights for better trial planning and cost reduction.
Main Methods:
- Utilized a dataset of 311,260 trials to create a testbed of 68,999 samples.
- Engineered 640 features encompassing trial administration, eligibility, study information, and criteria.
- Employed feature ranking, sampling, and ensemble learning techniques for analysis and prediction.
Main Results:
- Feature ranking identified key factors related to termination, including trial eligibility and inclusion/exclusion criteria.
- Achieved over 67% Balanced Accuracy and 0.73 AUC (Area Under the Curve) in predicting clinical trial termination.
- Demonstrated the efficacy of machine learning in achieving satisfactory prediction results for clinical trial studies.
Conclusions:
- Machine learning offers a viable approach to understanding and predicting clinical trial termination.
- Identifying key predictive features can guide stakeholders in proactive trial design and management.
- Accurate prediction of trial termination can lead to significant cost savings and improved research outcomes.
Related Concept Videos
Survival Tree
236
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
236
End Point Prediction: Gran Plot
881
A Gran plot is used to predict the equivalence volume or endpoint of a potentiometric or acid-base titration without reaching the endpoint. Typically, titration data is collected as a function of the titrant's volume up to a point less than the equivalence volume and then transformed into a linear format. The straight line is extended to the x-axis, indicating the necessary titrant volume to achieve the equivalence point.
For potentiometric titration, the Gran plot is created by plotting...
For potentiometric titration, the Gran plot is created by plotting...
881
Kaplan-Meier Approach
393
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
393
Clinical Trials
10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.0K
Clinical Trials: Overview
4.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.2K
Truncation in Survival Analysis
403
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
403


